Stock listing
Molecure Sa
Selected listing: MOC · GPW · PLN · PL
Molecure Sa (GPW:MOC), Health Technology. Latest release Aug 3, 2026: Molecure Receives Positive IDMC Recommendation to Continue the KITE Clinical Trial…
- Ticker
- GPW:MOC
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GPW
- Currency
- PLN
About Molecure Sa
Molecure SA is a public company listed on the Polish market under the ticker MOC. Molecure focuses on developing innovative therapies in the pharmaceutical sector.
Latest news from Molecure Sa
Molecure Receives Positive IDMC Recommendation to Continue the KITE Clinical Trial Without Changes to the Study Protocol (OATD-01 Development Program)
August 3, 2026
Strategic update on the progress and development of Molecure's key clinical projects in 2024
March 28, 2025
Avicenna Biosciences and Molecure S.A. Sign Strategic Research Collaboration Agreement to Accelerate Discovery and Development of Small Molecule Drugs
July 31, 2024
Molecure Announces Details for Virtual R&D Day Webcast to be held on Wednesday 7th December 2022
December 6, 2022
Research Molecure Sa
Alternate listings
A2JJ69:LSX
DE · EUR
Alternate listing for Molecure Sa; the primary context on this page is MOC:GPW.
A2JJ69:LS
DE · EUR
Alternate listing for Molecure Sa; the primary context on this page is MOC:GPW.
1B1:GETTEX
DE · EUR
Alternate listing for Molecure Sa; the primary context on this page is MOC:GPW.
1B1:FWB
DE · EUR
Alternate listing for Molecure Sa; the primary context on this page is MOC:GPW.
1B1:MUN
DE · EUR
Alternate listing for Molecure Sa; the primary context on this page is MOC:GPW.
1B1:SWB
DE · EUR
Alternate listing for Molecure Sa; the primary context on this page is MOC:GPW.